Premium
Do we really need long‐term hepatitis B hyperimmune globulin? What are the alternatives?
Author(s) -
Lake John R.
Publication year - 2008
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.21637
Subject(s) - medicine , liver transplantation , hepatitis b immune globulin , hepatitis b , antiviral treatment , immunology , virology , hepatitis b virus , chronic hepatitis , transplantation , intensive care medicine , hbsag , virus
Key Points1 The outcomes of liver transplantation for patients with hepatitis are the best for any diagnosis. 2 Prevention of HBV re‐infection is the key to excellent outcomes after liver transplantation. 3 The use of hepatitis B immunoglobulin to prevent HBV re‐infection is effective, but costly and with side effects. 4 Effective prophylaxis against HBV re‐infection can now be accomplished with combination nucleoside/nucleotide anti‐virals.Liver Transpl 14:S23–S26, 2008. © 2008 AASLD.